Back
Zenas BioPharma, Inc. Stock Price Chart
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
48
ZBIO
Zenas BioPharma, Inc.
Last Price:
$19.95
Seasonality Move:
-8.72%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
Zenas BioPharma, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.09 | Buy |
| 20-day SMA: | 30.29 | Sell |
| 50-day SMA: | 33.82 | Sell |
| 200-day SMA: | 19.69 | Buy |
| 8-day EMA: | 21.9 | Buy |
| 20-day EMA: | 27.28 | Sell |
| 50-day EMA: | 30.3 | Sell |
| 200-day EMA: | 23.12 | Sell |
Zenas BioPharma, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.75 | Sell |
| Relative Strength Index (14 RSI): | 39.44 | Sell |
| Chaikin Money Flow: | 747123 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.96 - 41.76) | Sell |
| Bollinger Bands (100): | (19.52 - 36.42) | Sell |
Zenas BioPharma, Inc. Technical Analysis
| Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | Jan 12 | Jan 13 | Jan 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 31 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Zenas BioPharma, Inc. Stock
Is Zenas BioPharma, Inc. Stock a Buy?
-
Zenas BioPharma, Inc. share price is 22.56 while ZBIO 8-day simple moving average is 18.09, which is a Buy signal.
-
The stock price of ZBIO is 22.56 while Zenas BioPharma, Inc. 20-day SMA is 30.29, which makes it a Sell.
-
Zenas BioPharma, Inc. 50-day simple moving average is 33.82 while ZBIO share price is 22.56, making it a Sell technically.
-
ZBIO stock price is 22.56 and Zenas BioPharma, Inc. 200-day simple moving average is 19.69, creating a Buy signal.
ZBIO Technical Analysis vs Fundamental Analysis
Sell
48
Zenas BioPharma, Inc. (ZBIO)
is a Sell
Is Zenas BioPharma, Inc. a Buy or a Sell?
-
Zenas BioPharma, Inc. stock is rated a SellThe current Zenas BioPharma, Inc. [ZBIO] share price is $22.56. The Score for ZBIO is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Zenas BioPharma, Inc. Stock Info
Market Cap:
943.8M
Price in USD:
22.56
Share Volume:
774.3K
Zenas BioPharma, Inc. 52-Week Range
52-Week High:
44.60
52-Week Low:
5.83
Sell
48
Zenas BioPharma, Inc. (ZBIO)
is a Sell
Zenas BioPharma, Inc. Share Price Forecast
-
What is the Zenas BioPharma, Inc. stock price today?The Zenas BioPharma, Inc. stock price is 22.56 USD today.
-
Will ZBIO stock go up or go down?Zenas BioPharma, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Zenas BioPharma, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Zenas BioPharma, Inc. is overvalued.
Is Zenas BioPharma, Inc. Stock a Buy?
-
Zenas BioPharma, Inc. share price is 22.56 while ZBIO 8-day exponential moving average is 21.90, which is a Buy signal.
-
The stock price of ZBIO is 22.56 while Zenas BioPharma, Inc. 20-day EMA is 27.28, which makes it a Sell.
-
Zenas BioPharma, Inc. 50-day exponential moving average is 30.30 while ZBIO share price is 22.56, making it a Sell technically.
-
ZBIO stock price is 22.56 and Zenas BioPharma, Inc. 200-day simple moving average is 23.12, creating a Sell signal.
Fundamental Analysis of Zenas BioPharma, Inc.
Is Zenas BioPharma, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.22 per share.
Technical Analysis of Zenas BioPharma, Inc.
Should I short Zenas BioPharma, Inc. stock?
-
ZBIO Moving Average Covergence Divergence (MACD) indicator is -4.75, suggesting Zenas BioPharma, Inc. is a Sell
-
Zenas BioPharma, Inc. Relative Strength Index (RSI) is 39.44, which suggest Zenas BioPharma, Inc. is oversold
-
The Bollinger Bands (25) for Zenas BioPharma, Inc. is (21.96 - 41.76), which suggest Zenas BioPharma, Inc. is a Sell
-
The Bollinger Bands (100) for Zenas BioPharma, Inc. is (19.52 - 36.42), which suggest Zenas BioPharma, Inc. is a Sell
* Zenas BioPharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.